Immediate Impact
6 from Science/Nature 51 standout
Citing Papers
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
2022 Standout
Works of V. Kaloutsi being referenced
Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma.
2009
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| V. Kaloutsi | 537 | 438 | 195 | 41 | 858 | |
| John Dervenoulas | 341 | 201 | 235 | 56 | 923 | |
| Mitchell A. Bitter | 554 | 231 | 397 | 23 | 1.1k | |
| Hans‐Eckart Schaefer | 393 | 256 | 58 | 47 | 978 | |
| E. Papageorgiou | 337 | 218 | 251 | 48 | 849 | |
| H. Choritz | 631 | 579 | 68 | 32 | 1.0k | |
| Takafumi Matsushima | 406 | 257 | 261 | 56 | 910 | |
| Eric M. Bonnem | 355 | 161 | 150 | 36 | 982 | |
| Ellen G. van Lochem | 173 | 152 | 211 | 27 | 1.1k | |
| Masanao Teramura | 555 | 181 | 117 | 42 | 850 | |
| Dolors Costa | 391 | 409 | 275 | 73 | 1.1k |
All Works
Loading papers...